Effect of melatonin on sleep quality in breast cancer patients during chemotherapy
Not Applicable
Recruiting
- Conditions
- Breast cancer.Malignant neoplasm: Breast, unspecified
- Registration Number
- IRCT20150726023349N4
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Patients who are in stage one to three breast cancer and cancer surgery is performed within the last three months.
No history of prior chemotherapy
No contraindication for adjuvant chemotherapy of breast cancer (including heart failure and drug hypersensitivity)
40 to 60 years old at the onset of chemotherapy
The absence of uncontrolled diabetes and renal failure with glomerular filtration less than 30
Exclusion Criteria
Delay or discontinuation of chemotherapy over one month for any reason
Sleep disorder, depression and anxiety requiring drug treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality. Timepoint: Before start of chemothrapy, after forth cycle and at of the chemothrapy. Method of measurement: Pittsburgh sleep quality index.
- Secondary Outcome Measures
Name Time Method